TORI 104 Pre-Surgical Dasatinib

A Study to Assess the Pharmacokinetics and Safety of Different Forms and Formulations of AZD9496 in Healthy Subjects

NCT02780713 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity

NCT00459771 ·Status: COMPLETED ·Phase: PHASE3

Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women

NCT00107016 ·Status: COMPLETED ·Phase: PHASE2

Pre-Surgical Intervention for Targeted Therapies for Breast Cancer

NCT01004744 ·Status: COMPLETED ·Phase: NA

A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)

NCT02273973 ·Status: COMPLETED ·Phase: PHASE2

Letrozole After Tamoxifen in Treating Women With Breast Cancer

NCT00003140 ·Status: COMPLETED ·Phase: PHASE3

Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer

NCT01077453 ·Status: COMPLETED ·Phase: PHASE1

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

NCT02598557 ·Status: COMPLETED ·Phase: PHASE2

Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women

NCT00056082 ·Status: COMPLETED ·Phase: PHASE2

Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer

NCT03747042 ·Status: COMPLETED ·Phase: PHASE2

Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence

NCT01081509 ·Status: COMPLETED

Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10%

NCT05659563 ·Status: COMPLETED ·Phase: PHASE2

Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer

NCT05982093 ·Status: RECRUITING ·Phase: PHASE2

A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol.

NCT01745965 ·Status: COMPLETED ·Phase: PHASE2

The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer

NCT05507398 ·Status: UNKNOWN ·Phase: PHASE4

Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast Cancer

NCT01695226 ·Status: COMPLETED ·Phase: PHASE2

Study of Breast Cancer Prevention by Letrozole in High Risk Women

NCT00579826 ·Status: COMPLETED ·Phase: PHASE2

Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02

NCT00975676 ·Status: COMPLETED ·Phase: NA

A Study of R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast Cancer

NCT00796107 ·Status: TERMINATED ·Phase: PHASE2

Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4)

NCT01064635 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment

NCT00737009 ·Status: COMPLETED

Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer

NCT01138553 ·Status: TERMINATED ·Phase: EARLY_PHASE1

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

NCT00237211 ·Status: COMPLETED ·Phase: PHASE2

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

NCT00637481 ·Status: COMPLETED ·Phase: PHASE1

Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer

NCT01082068 ·Status: COMPLETED ·Phase: PHASE1/PHASE2